Literature DB >> 10787795

Access to health care in the Scandinavian countries: ethical aspects.

S Holm1, P E Liss, O F Norheim.   

Abstract

The health care systems are fairly similar in the Scandinavian countries. The exact details vary, but in all three countries the system is almost exclusively publicly funded through taxation, and most (or all) hospitals are also publicly owned and managed. The countries also have a fairly strong primary care sector (even though it varies between the countries), with family physicians to various degrees acting as gatekeepers to specialist services. In Denmark most of the GP services are free. For the patient in Norway and Sweden there are out-of-pocket co-payments for GP consultations, with upper limits, but consultations for children are free. Hospital treatment is free in Denmark while the other countries use a system with out-of-pocket co-payment. There is a very strong public commitment to access to high quality health care for all. Solidarity and equality form the ideological basis for the Scandinavian welfare state. Means testing, for instance, has been widely rejected in the Scandinavian countries on the grounds that public services should not stigmatise any particular group. Solidarity also means devoting special consideration to the needs of those who have less chance than others of making their voices heard or exercising their rights. Issues of limited access are now, however, challenging the thinking about a health care system based on solidarity.

Entities:  

Keywords:  Health Care and Public Health

Mesh:

Year:  1999        PMID: 10787795     DOI: 10.1023/A:1009460010196

Source DB:  PubMed          Journal:  Health Care Anal        ISSN: 1065-3058


  3 in total

1.  Norway's decentralized, single-payer health system faces great challenges.

Authors:  M Nylenna
Journal:  JAMA       Date:  1995-07-12       Impact factor: 56.272

2.  [High-dose therapy with stem cell support and support by a cabinet minister].

Authors:  M Nylenna; C Haug; A Bjørndal
Journal:  Tidsskr Nor Laegeforen       Date:  1996-09-10

3.  [Prioritizing in practice. Thinking about it, wishing it, then doing it!].

Authors:  L Brinch; S A Evensen; J P Blomhoff; D Albrechtsen
Journal:  Tidsskr Nor Laegeforen       Date:  1993-11-10
  3 in total
  10 in total

1.  Predictors of long-term cognitive outcome in Alzheimer's disease.

Authors:  Carina Wattmo; Asa K Wallin; Elisabet Londos; Lennart Minthon
Journal:  Alzheimers Res Ther       Date:  2011-07-20       Impact factor: 6.982

2.  Epidemiology of chronic pain in denmark and sweden.

Authors:  Julie Harker; Kim J Reid; Geertruida E Bekkering; Eliane Kellen; Malgorzata M Bala; Rob Riemsma; Gill Worthy; Kate Misso; Jos Kleijnen
Journal:  Pain Res Treat       Date:  2012-05-23

3.  Cholinesterase inhibitors do not alter the length of stay in nursing homes among patients with Alzheimer's disease: a prospective, observational study of factors affecting survival time from admission to death.

Authors:  Carina Wattmo; Elisabet Londos; Lennart Minthon
Journal:  BMC Neurol       Date:  2016-08-31       Impact factor: 2.474

4.  Cocreated Smartphone App to Improve the Quality of Life of Adolescents and Young Adults with Cancer (Kræftværket): Protocol for a Quantitative and Qualitative Evaluation.

Authors:  Abbey Elsbernd; Maiken Hjerming; Camilla Visler; Lisa Lyngsie Hjalgrim; Carsten Utoft Niemann; Kirsten Boisen; Helle Pappot
Journal:  JMIR Res Protoc       Date:  2018-05-10

5.  Awareness of polycystic ovary syndrome among obstetrician-gynecologists and endocrinologists in Northern Europe.

Authors:  Terhi T Piltonen; Maria Ruokojärvi; Helle Karro; Linda Kujanpää; Laure Morin-Papunen; Juha S Tapanainen; Elisabet Stener-Victorin; Inger Sundrström-Poromaa; Angelica L Hirschberg; Pernille Ravn; Dorte Glintborg; Jan Roar Mellembakken; Thora Steingrimsdottir; Melanie Gibson-Helm; Eszter Vanky; Marianne Andersen; Riikka K Arffman; Helena Teede; Kobra Falah-Hassani
Journal:  PLoS One       Date:  2019-12-26       Impact factor: 3.240

6.  Response to cholinesterase inhibitors affects lifespan in Alzheimer's disease.

Authors:  Carina Wattmo; Elisabet Londos; Lennart Minthon
Journal:  BMC Neurol       Date:  2014-09-10       Impact factor: 2.474

7.  Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy.

Authors:  Carina Wattmo; Lennart Minthon; Åsa K Wallin
Journal:  Alzheimers Res Ther       Date:  2016-02-17       Impact factor: 6.982

8.  The perception of youth health centres' friendliness: does it differ between immigrant and Swedish-Scandinavian youths?

Authors:  Mazen Baroudi; Miguel San Sebastian; Anna-Karin Hurtig; Isabel Goicolea
Journal:  Eur J Public Health       Date:  2020-08-01       Impact factor: 3.367

9.  Who prescribes drugs to patients: A Danish register-based study.

Authors:  Anton Pottegård; Morten Olesen; Bo Christensen; Morten Bondo Christensen; Jesper Hallas; Lotte Rasmussen
Journal:  Br J Clin Pharmacol       Date:  2021-01-25       Impact factor: 4.335

10.  Mortality in Norway and Sweden during the COVID-19 pandemic.

Authors:  Frederik E Juul; Henriette C Jodal; Ishita Barua; Erle Refsum; Ørjan Olsvik; Lise M Helsingen; Magnus Løberg; Michael Bretthauer; Mette Kalager; Louise Emilsson
Journal:  Scand J Public Health       Date:  2021-10-05       Impact factor: 3.021

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.